08/11/2025
BREAKING: Hospitals Reclassify mRNA Vaccines as “Biogenic Injections”–Administered Without Patient Consent
An in-depth investigative report from The People’s Voice reveals that major hospitals in the United States and internationally have quietly reclassified mRNA COVID-19 vaccines, moving them out of the standard “vaccine” category and into “Class IV biogenic agents.”
This is the same classification reserved for high-risk biological materials that require specialized containment, rigorous biosafety measures, and extensive tracking due to their ability to interact with or modify human genetic material.
Leaked internal documents from leading institutions such as Johns Hopkins and the Mayo Clinic show updated pharmacovigilance protocols, new storage and handling guidelines, and revised staff training materials that reflect this shift.
In practice, the reclassification changes how these injections are managed across hospital systems—from procurement and inventory to administration and post-injection monitoring.
Whistleblowers, including nurses and hospital administrators, describe a disturbing pattern: patients in emergency departments, under sedation, or receiving psychiatric care have received these injections without being informed of the new classification or given the opportunity to consent.
One insider shared that staff were directed to treat the shots as “mandatory public health emergency interventions,” where consent is assumed unless a fully conscious patient actively refuses—and in many documented cases, refusals were disregarded under institutional policy.
The legal implications are significant.
By redefining mRNA products outside the traditional vaccine framework, manufacturers like Pfizer and Moderna may access broader liability protections, especially as public scrutiny grows over long-term safety data and documented increases in excess mortality following widespread rollout.
The trend extends beyond the U.S. The UK’s National Health Service and several European hospital networks have reportedly adopted similar internal protocols.
Patients previously identified as “vaccine hesitant” now appear flagged in electronic health records, prioritizing them for administration during routine visits, emergencies, or involuntary holds.
This reclassification fundamentally alters the trust between healthcare providers and patients, particularly around informed consent and bodily autonomy.
Healthcare workers, ethicists, policymakers, and the public must demand full transparency from hospital leadership, regulatory agencies, and pharmaceutical oversight bodies.
